The information in this section is intended solely for the medical and pharmaceutical industry and may only be used in professional activities.
ARE YOU A MEDICAL AND/OR A PHARMACEUTICAL WORKER?
(Choosing an answer, you are responsible for the accuracy of the information provided)
YES, I am a medical/pharmaceutical worker
NO, I am not a medical/pharmaceutical worker
VIRORIB CAPSULES
PHARMACEUTICAL FORM :
Capsules
ATC class :
Direct-acting antiviral agents
Active substance :
RIBAVIRIN
Composition: :
Each capsule contains 200 mg of ribavirin
Indications for use:
In combination with peginterferon alfa-2a or interferon alfa-2a for the treatment of chronic hepatitis C in adult patients, in whose serum a positive reaction to HCV-RNA is determined, including patients with cirrhosis in the stage of compensation. Combination therapy with Virorib and peginterferon alfa-2a in patients in whom previous treatment with interferon alfa (pegylated or non-pegylated) in monotherapy or in combination with ribavirin was ineffective.
